CT低灌注指数与中大型血管闭塞性卒中缺血核心扩大的关系
研究纳入106例急性卒中患者,用CT灌注评估低灌注指数(HI)与梗死核心进展速率的关系,并在110例独立队列中验证。HI>0.5与快速核心进展相关,区分快慢进展者的AUC为0.94(95%CI 0.80-0.99),验证队列AUC为0.84(95%CI 0.72-0.97)。
要点
- HI>0.5可区分中血管闭塞与大血管闭塞卒中24小时内的快速与缓慢核心进展。
- HI>0.5者核心进展速率约0.2-0.3 mL/min,明显高于HI≤0.5者。
- 评估核心进展速率可能有助于筛选再灌注治疗患者,尚需进一步研究。
核心结论
- HI能在急性缺血性卒中发病24小时内区分中血管闭塞与大血管闭塞患者的快速与缓慢核心进展。
研究设计与样本
- 研究评估106例急性卒中并行CT灌注患者的梗死核心进展,并在110例急性缺血性卒中独立队列中验证HI阈值。
主要发现
- 106例中快速进展者占6.6%、缓慢进展者占27.4%、66%无法按再灌注试验核心时间标准分类。
- HI>0.5区分快慢进展者的AUC为0.94(95%CI 0.80-0.99)。
- 中血管闭塞HI>0.5者核心进展0.30 mL/min,HI≤0.5者为0.03 mL/min(p<0.001)。
- 大血管闭塞HI>0.5者核心进展0.26 mL/min,HI≤0.5者为0.02 mL/min(p<0.001)。
- 验证队列HI>0.5区分快慢核心进展的AUC为0.84(95%CI 0.72-0.97)。
关键数值与推荐
- 快速进展者定义为发病6小时内核心>70 mL,缓慢进展者定义为6至24小时内核心≤70 mL、错配≥15 mL且错配与核心比值≥1.8。
- HI>0.5为区分快速与缓慢核心进展的阈值。
临床怎么用
- 卒中评估时可结合HI判断核心进展速率,辅助中血管闭塞与大血管闭塞患者的再灌注治疗筛选,但需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The rate of infarct core progression in patients with acute ischemic stroke is variable and affects outcome of reperfusion therapy. We evaluated the hypoperfusion index (HI) to estimate the initial rate of core progression in patients with medium vessel occlusion (MeVO) compared to large vessel occlusion (LVO) stroke and within a larger time frame since stroke onset. METHODS: Core progression was assessed in 106 patients with acute stroke and CT perfusion. Using reperfusion trial core time criteria, fast progressors had core >70 mL within 6 hours of stroke onset and slow progressors had core ≤70 mL, mismatch ≥15 mL, and mismatch to core ratio ≥1.8 within 6 to 24 hours. The relationship between HI and infarct core progression (core/time) was examined using receiver operating characteristics to determine optimal HI cutoff. The HI cutoff was then tested in the overall cohort, compared between MeVO and LVO, and evaluated in patients up to 24 hours from stroke onset to differentiate fast from slow rate of core progression. HI threshold was assessed in a second independent cohort of 110 patients with acute ischemic stroke. RESULTS: In 106 patients with acute stroke, 6.6% were fast progressors, 27.4% were slow progressors, and 66% were not classified as fast or slow progressor by reperfusion trial core time criteria. HI >0.5 was associated with fast progression and able to distinguish fast from slow progressors (area under the curve [AUC] 0.94; 95% confidence interval [CI] 0.80-0.99). In MeVO (n = 26) HI >0.5 had a core progression of 0.30 mL/min compared to 0.03 mL/min for HI ≤0.5 (p < 0.001). In LVO (n = 80), HI >0.5 had a core progression of 0.26 mL/min compared to 0.02 mL/min for HI ≤0.5 (p < 0.001). In patients not classified as fast or slow progressor by reperfusion trial criteria, those with HI >0.5 had progression rate of 0.21 mL/min compared to 0.03 mL/min for those with HI ≤0.5 (p < 0.001). Validation in a second cohort of patients with acute ischemic stroke (n = 110; MeVO = 42, LVO = 68) yielded similar results for HI >0.5 to distinguish fast and slow core progression with an AUC of 0.84 (95% CI 0.72-0.97). DISCUSSION: HI can differentiate fast from slow core progression in MeVO and LVO within the first 24 hours of acute ischemic stroke. Consideration of core progression rate at time of stroke evaluation may have implications in the selection of patients with MeVO and LVO stroke for reperfusion therapy that warrant further study.
引用
- Nomani AZ, Kamtchum Tatuene J, Rempel JL, et al. Association of CT-Based Hypoperfusion Index With Ischemic Core Enlargement in Patients With Medium and Large Vessel Stroke. Neurology. 2021. PMID: 34607925. doi:10.1212/WNL.0000000000012855
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。